| Integrated design of biopharmaceutical manufacturing processes: Operation modes and process configurations for monoclonal antibody production S Badr, K Okamura, N Takahashi, V Ubbenjans, H Shirahata, H Sugiyama Computers & Chemical Engineering 153, 107422, 2021 | 27 | 2021 |
| Cost–benefit analysis of monoclonal antibody cultivation scenarios in terms of life cycle environmental impact and operating cost E Amasawa, H Kuroda, K Okamura, S Badr, H Sugiyama ACS Sustainable Chemistry & Engineering 9 (42), 14012-14021, 2021 | 20 | 2021 |
| Hybrid modeling of CHO cell cultivation in monoclonal antibody production with an impurity generation module K Okamura, S Badr, S Murakami, H Sugiyama Industrial & Engineering Chemistry Research 61 (40), 14898-14909, 2022 | 14 | 2022 |
| Determination of critical decision points for COVID-19 measures in Japan J Kim, K Matsunami, K Okamura, S Badr, H Sugiyama Scientific Reports 11 (1), 16416, 2021 | 3 | 2021 |
| Hybrid Modelling of CHO-MK Cell Cultivation in Monoclonal Antibody Production K Okamura, S Badr, S Murakami, H Sugiyama Computer Aided Chemical Engineering 49, 2137-2142, 2022 | 1 | 2022 |
| Integrated Design of Biopharmaceutical Manufacturing Processes: Operation Modes and Process Configurations for Monoclonal Antibody Production S Badr, K Okamura, N Takahashi, V Ubbenjans, H Shirahata, H Sugiyama Computer Aided Chemical Engineering 48, 1609-1614, 2020 | 1 | 2020 |
| Scenario Analysis of Vaccine Supply for COVID-19 in Japan Using Mathematical Models of Infectious Diseases J Kim, K Matsunami, Y Ichida, K Okamura, S Badr, H Sugiyama Journal of Chemical Engineering of Japan 57 (1), 2313318, 2024 | | 2024 |
| A Systems Evaluation Model for the Development of Companion Diagnostics and Associated Molecularly Targeted Therapies K Okamura, H Tsuchiya, R Hamada, Y Hayashi, S Badr, S Ohta, ... Journal of Pharmaceutical Innovation 18 (4), 2265-2276, 2023 | | 2023 |
| Modeling and Dynamic Simulation of Cultivation in Monoclonal Antibody Production Considering Cell Metabolic Shifts K Okamura, S Badr, A Yamada, H Sugiyama 2023 AIChE Annual Meeting, 2023 | | 2023 |
| Correction to “Cost–Benefit Analysis of Monoclonal Antibody Cultivation Scenarios in Terms of Life Cycle Environmental Impact and Operating Cost” E Amasawa, H Kuroda, K Okamura, S Badr, H Sugiyama ACS Sustainable Chemistry & Engineering 11 (39), 14645-14645, 2023 | | 2023 |
| Hybrid modelling and data-driven parameterization of monoclonal antibody cultivation processes: Shifts in cell metabolic behavior S Badr, K Oishi, K Okamura, S Murakami, H Sugiyama Computer Aided Chemical Engineering 52, 985-990, 2023 | | 2023 |
| Techno-economic Assessment of Upstream and Downstream Process Alternatives for the Production of Monoclonal Antibodies S Badr, K Okamura, N Takahashi, H Sugiyama Computer Aided Chemical Engineering 49, 745-750, 2022 | | 2022 |
| Design of Integrated Monoclonal Antibody Production Processes: Modelling, Data, and Process Challenges S Badr, K Okamura, N Takahashi, H Sugiyama 2020 Virtual AIChE Annual Meeting, 2020 | | 2020 |
| Design of Integrated Monoclonal Antibody Production: Opportunities for Continuous Manufacturing S Badr, K Okamura, N Takahashi, H Shirahata, H Sugiyama 2019 AIChE Annual Meeting, 2019 | | 2019 |
| Dynamic Simulation and Process Assessment of Cultivation Modes in Monoclonal Antibody Production Using Pilot-Scale Experimental Data K Okamura, S Badr, H Sugiyama 2019 AIChE Annual Meeting, 2019 | | 2019 |
